Investigation of inpatients with chronic kidney disease in a tertiary referral hospital in Shanghai from 2011 to 2016

Jun-rui LONG,Chan-juan SHAN,Qun-di YANG,Xin-ying LIU,Jiu-sheng WANG,Chang-lin MEI,Lin-ping XIONG

DOI: https://doi.org/10.16781/j.0258-879x.2018.01.0013

2018-01-01

Abstract:Objective To analyze the demographic information and related costs of inpatients with chronic kidney disease (CKD) in a tertiary referral hospital in Shanghai from 2011 to 2016, so as to provide reference for further understanding and improving the current situation of medical treatment of patients with CKD in Shanghai. Methods We retrospectively reviewed the clinical data (age, gender, hospital stay, disease diagnosis, hospitalization expenses and so on) of inpatients with CKD in a tertiary referral hospital in Shanghai from 2011 to 2016. The general characteristics and disease diagnosis of the inpatients with CKD were statistically analyzed by calculating the proportion of each index using a simple statistical description method. The treatment, hospitalization expenses of the inpatients with CKD were compared between different groups by variance analysis and non-parametric test. Results The percent of inpatients from Jiangsu, Zhejiang, Anhui and Jiangxi provinces around Shanghai was 49.97% (10033/20079), surpassing that of inpatients from Shanghai (38.78%, 7787/20079). The proportion of inpatients with chronic renal failure was the highest (51.98%, 10438/20079), and more young people tended to suffer from the disease. The per capita hospitalization expense was increased annually, and the median hospitalization expense was 8252.51 yuan in 2016. There were significant differences in per capita hospitalization expenses between the different year groups (P<0.001). Conclusion Active and effective measures should be taken to deal with the problem of large numbers of nonlocal patients seeking medical services in Shanghai. It is necessary to popularize the knowledge about CKD in young people, and reduce the social and personal losses due to the illness. The economic burden caused by CKD needs to be further studied.